Chronic action of association of zidovudine, lamivudine and ritonavir on pregnant rats. A biologic assay.
To evaluate at term the effects of a highly active antiretroviral (HAAR) drug association administered during the entire period of rat pregnancy. Three groups (n = 10 each) of adult pregnant rats were treated with an oral solution of HAAR (Exp 1 = 10/5/20 mg/kg b.w.; Exp 2 = 30/15/60 mg/kg b.w.; Exp 3 = 90/45/180 mg/kg b.w.) from day "0" up to the 20th day of pregnancy. A fourth group served as a control. At term (20th day) the rats were killed under deep anesthesia and the number of implantations, resorptions, living fetuses, placentae and intrauterine deaths were recorded. The highest HAAR doses caused lower maternal weight gain, lower litter weights, and lower placental weights compared to the control group. HAAR during the entire period of rat pregnancy can reduce maternal body weight gain and lower term placental weight.